Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System

• Main Authors: Elena Mirabela Velișcu (Author), Valerio Liguori (Author), Antonietta Anatriello (Author), Giorgia Teresa Maniscalco (Author), Andrea Cantone (Author), Luigi Di Costanzo (Author), Pasquale Stefanelli (Author), Cristina Scavone (Author), Annalisa Capuano (Author)
• Format: Book
• Published: MDPI AG, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Cladribine belongs to the group of disease-modifying therapies (DMTs) used to treat multiple sclerosis (MS). According to the highlights of a meeting held by the Pharmacovigilance Risk Assessment Committee (PRAC) on 14 January 2022, cladribine may be associated with the occurrence of liv...